Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

DARK SECRETS: 48 | Rare Historical Photos

Amdocs (NASDAQ:DOX) reported fiscal second-quarter 2026 revenue and non-GAAP earnings above the midpoint of its guidance, while newly appointed Chief Executive Officer Shimie Hortig used the company’s earnings call to outline a strategy centered on “agentic” artificial intelligence for telecom opera

MarketBeat

Cisco Systems Q3 Earnings Call Highlights

Cisco Systems (NASDAQ:CSCO) reported record fiscal third-quarter revenue and raised its expectations for artificial intelligence infrastructure orders, as executives said demand accelerated across hyperscale, enterprise and public-sector customers. Chair and CEO Chuck Robbins said Cisco delivered “

MarketBeat

ICL Group Q1 Earnings Call Highlights

ICL Group (NYSE:ICL) reported a stronger first quarter for 2026, with management citing higher bromine and potash prices, broad segment sales growth and operational improvements, while also warning that elevated raw material costs and foreign exchange headwinds remain key risks for the rest of the y

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

Advanced Micro Devices Shareholders Back Board as Lisa Su Touts AI Growth

Advanced Micro Devices (NASDAQ:AMD) used its 2026 Annual Stockholders Meeting to secure shareholder approval for its director slate and key governance items, while Chair and CEO Lisa Su outlined the company’s growth strategy centered on artificial intelligence and data center computing. The virtual

MarketBeat

Franco-Nevada Q1 Earnings Call Highlights

Franco-Nevada (NYSE:FNV) reported record first-quarter 2026 financial results, with management citing higher precious metals prices, recent acquisitions and strong contributions from several key assets as the main drivers of performance. President and CEO Paul Brink said the company posted record r

MarketBeat

Flex LNG Q1 Earnings Call Highlights

Flex LNG (NYSE:FLNG) reported first-quarter 2026 net income of $19.5 million, or $0.36 per share, as management said scheduled drydockings and a softer early-quarter spot market weighed on results but improving LNG carrier rates and new contract coverage supported an upgraded full-year outlook. Chi

MarketBeat

Ecopetrol Q1 Earnings Call Highlights

Ecopetrol (NYSE:EC) reported first-quarter 2026 revenue of COP 28.6 trillion, EBITDA of COP 13.5 trillion and net income of COP 2.9 trillion, as management said stronger refining results and cost controls helped offset currency, logistics and market pressures. Juan Carlos Hurtado Parra, Ecopetrol’s

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

Dynatrace Q4 Earnings Call Highlights

Dynatrace (NYSE:DT) reported a stronger finish to fiscal 2026, with executives emphasizing steady annual recurring revenue growth, expanding consumption of its log management products and growing demand tied to artificial intelligence and cloud complexity. On the company’s fourth-quarter and full-y

MarketBeat

Alnylam Pharmaceuticals Backs TTR Outlook as AMVUTTRA Access, Prescriber Growth Build

Alnylam Pharmaceuticals (NASDAQ:ALNY) Chief Financial Officer Jeff Poulton said the company remains confident in its TTR revenue guidance despite a slower first-quarter sequential growth rate, pointing to access, international launches and prescriber expansion as key drivers for the rest of the year

MarketBeat

Birkenstock Q2 Earnings Call Highlights

Birkenstock (NYSE:BIRK) reported fiscal second-quarter revenue growth within its target range on a constant-currency basis, while management said foreign exchange, tariffs, inflation and disruptions tied to conflict in the Middle East weighed on reported results and margins. The footwear company ge

MarketBeat

Alibaba Group Q4 Earnings Call Highlights

Alibaba Group (NYSE:BABA) said its stepped-up investments in artificial intelligence, cloud computing and consumption businesses are beginning to translate into faster revenue growth, even as those investments weighed heavily on adjusted earnings and free cash flow in the March quarter. On the comp

MarketBeat

American Integrity Insurance Group Q1 Earnings Call Highlights

American Integrity Insurance Group (NYSE:AII) reported first-quarter 2026 net income available to common shareholders of $19.9 million, or $1.02 per diluted share, down from $35.9 million, or $2.78 per diluted share, in the prior-year period, as management said last year’s results benefited from ele

MarketBeat

Swarmer Q1 Earnings Call Highlights

Swarmer (NASDAQ:SWMR) reported a sharp year-over-year decline in first-quarter revenue in its first earnings call as a public company, while management emphasized that the company is investing in platform development, partnerships and international expansion as it seeks to position its autonomy soft

MarketBeat

Alignment Healthcare Backs Q2 Outlook as Stable Costs, New Markets Lift Margin Hopes

Alignment Healthcare (NASDAQ:ALHC) executives said the company remains confident in its second-quarter outlook, citing stable medical cost trends, continued visibility into utilization and opportunities to expand margins as it grows outside California. Speaking at an analyst-led question-and-answer

MarketBeat

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Wix.com Q1 Earnings Call Highlights

Wix.com (NASDAQ:WIX) executives said the company delivered solid first-quarter 2026 growth while accelerating investments in artificial intelligence products, including Wix Harmony and Base44, during the company’s earnings call. President and Co-founder Nir Zohar said the company is focused on usin

MarketBeat

WeRide Q1 Earnings Call Highlights

WeRide (NASDAQ:WRD) reported first-quarter 2026 revenue growth of 58% year over year, as management pointed to expanding Robotaxi deployments, broader autonomous driving commercialization and traction for its L2++ advanced driver assistance system. Founder, Chairman and CEO Dr. Tony Han said total

MarketBeat

Valneva Q1 Earnings Call Highlights

Valneva (NASDAQ:VALN) reported lower first-quarter revenue and a wider loss for 2026, while management said the company is focused on conserving cash as it awaits the next regulatory steps for its Lyme disease vaccine candidate being developed with Pfizer. Chief Executive Officer Thomas Lingelbach

MarketBeat

D-Wave Earnings Looked Weak, But Investors May Be Missing This

D-Wave's long-awaited Q1 2026 earnings appear rough on the surface, with plunging revenue and widening losses, but many bright spots are hidden as well.

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Nebius Upside Expands as AI Feedback Loop Intensifies

Nebius Group is growing at a hyper pace as hyperscalers lean into it for data center capacity and AI-related services.

MarketBeat

Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell

See the recent insider activity surrounding Okta, Micron Technology, and Abbott Laboratories, and what these moves signal to investors.

MarketBeat

Torm Q1 Earnings Call Highlights

Torm (NASDAQ:TRMD) reported a sharply stronger first quarter of 2026 and raised its full-year outlook, citing firm freight markets, geopolitical disruptions and what management described as the company’s operating advantages in a highly volatile tanker market. Chief Executive Officer Jacob Meldgaar

MarketBeat

Sanuwave Health Q1 Earnings Call Highlights

Sanuwave Health (NASDAQ:SNWV) reported record first-quarter revenue and rising consumables utilization, while management said the advanced wound care market began to recover after a difficult start to the year tied to changes in reimbursement for skin substitutes. Chairman and CEO Morgan Frank said

MarketBeat

Regis Q3 Earnings Call Highlights

Regis (NASDAQ:RGS) reported higher profitability and positive cash flow in its fiscal third quarter of 2026, even as total revenue declined, as the salon franchisor pointed to cost controls, company-owned salon improvements and a sharper focus on its largest brands under new Chief Executive Officer

MarketBeat

PolyPid Q1 Earnings Call Highlights

PolyPid (NASDAQ:PYPD) said its first quarter marked a transition from late-stage clinical development toward regulatory submission and commercial preparation for D-PLEX100, its lead product candidate for preventing surgical site infections in abdominal colorectal surgery. Chief Executive Officer Di

MarketBeat

PDS Biotechnology Q1 Earnings Call Highlights

PDS Biotechnology (NASDAQ:PDSB) reported a smaller first-quarter loss and highlighted changes to its late-stage head and neck cancer trial that management said could shorten development timelines and reduce costs. On the company’s first quarter 2026 earnings call, Chief Executive Officer Dr. Frank

1 … 47 48 49 50

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.